Global Schizophrenia Therapeutic Market Growth (Status and Outlook) 2018-2023

October 2018 | 118 pages | ID: G4C012127D5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.
The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation.
Over the next five years, LPI(LP Information) projects that Schizophrenia Therapeutic will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Schizophrenia Therapeutic market for 2018-2023.

This report presents a comprehensive overview, market shares and growth opportunities of Schizophrenia Therapeutic market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Clozapine
• Ziprasidone
• Lurasidone
• Paliperidone

Segmentation by application:

• Hospitals
• Clinics
• Ambulatory Surgical Centers

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Eli Lilly
• Johnson and Johnson
• Pfizer
• Astrazeneca
• Bristol-Myers Squibb
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Schizophrenia Therapeutic market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Schizophrenia Therapeutic market by identifying its various subsegments.
• Focuses on the key global Schizophrenia Therapeutic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Schizophrenia Therapeutic with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Schizophrenia Therapeutic submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Schizophrenia Therapeutic Market Size 2013-2023
  2.1.2 Schizophrenia Therapeutic Market Size CAGR by Region
2.2 Schizophrenia Therapeutic Segment by Type
  2.2.1 Clozapine
  2.2.2 Ziprasidone
  2.2.3 Risperidone
  2.2.4 Lurasidone
  2.2.5 Paliperidone
2.3 Schizophrenia Therapeutic Market Size by Type
  2.3.1 Global Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
  2.3.2 Global Schizophrenia Therapeutic Market Size Growth Rate by Type (2013-2018)
2.4 Schizophrenia Therapeutic Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Ambulatory Surgical Centers
2.5 Schizophrenia Therapeutic Market Size by Application
  2.5.1 Global Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
  2.5.2 Global Schizophrenia Therapeutic Market Size Growth Rate by Application (2013-2018)

3 GLOBAL SCHIZOPHRENIA THERAPEUTIC BY PLAYERS

3.1 Global Schizophrenia Therapeutic Market Size Market Share by Players
  3.1.1 Global Schizophrenia Therapeutic Market Size by Players (2016-2018)
  3.1.2 Global Schizophrenia Therapeutic Market Size Market Share by Players (2016-2018)
3.2 Global Schizophrenia Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SCHIZOPHRENIA THERAPEUTIC BY REGIONS

4.1 Schizophrenia Therapeutic Market Size by Regions
4.2 Americas Schizophrenia Therapeutic Market Size Growth
4.3 APAC Schizophrenia Therapeutic Market Size Growth
4.4 Europe Schizophrenia Therapeutic Market Size Growth
4.5 Middle East & Africa Schizophrenia Therapeutic Market Size Growth

5 AMERICAS

5.1 Americas Schizophrenia Therapeutic Market Size by Countries
5.2 Americas Schizophrenia Therapeutic Market Size by Type
5.3 Americas Schizophrenia Therapeutic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Schizophrenia Therapeutic Market Size by Countries
6.2 APAC Schizophrenia Therapeutic Market Size by Type
6.3 APAC Schizophrenia Therapeutic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Schizophrenia Therapeutic by Countries
7.2 Europe Schizophrenia Therapeutic Market Size by Type
7.3 Europe Schizophrenia Therapeutic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Schizophrenia Therapeutic by Countries
8.2 Middle East & Africa Schizophrenia Therapeutic Market Size by Type
8.3 Middle East & Africa Schizophrenia Therapeutic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL SCHIZOPHRENIA THERAPEUTIC MARKET FORECAST

10.1 Global Schizophrenia Therapeutic Market Size Forecast (2018-2023)
10.2 Global Schizophrenia Therapeutic Forecast by Regions
  10.2.1 Global Schizophrenia Therapeutic Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Schizophrenia Therapeutic Forecast by Type
10.8 Global Schizophrenia Therapeutic Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Company Details
  11.1.2 Schizophrenia Therapeutic Product Offered
  11.1.3 Eli Lilly Schizophrenia Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Eli Lilly News
11.2 Johnson and Johnson
  11.2.1 Company Details
  11.2.2 Schizophrenia Therapeutic Product Offered
  11.2.3 Johnson and Johnson Schizophrenia Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Johnson and Johnson News
11.3 Pfizer
  11.3.1 Company Details
  11.3.2 Schizophrenia Therapeutic Product Offered
  11.3.3 Pfizer Schizophrenia Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Pfizer News
11.4 Astrazeneca
  11.4.1 Company Details
  11.4.2 Schizophrenia Therapeutic Product Offered
  11.4.3 Astrazeneca Schizophrenia Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Astrazeneca News
11.5 Bristol-Myers Squibb
  11.5.1 Company Details
  11.5.2 Schizophrenia Therapeutic Product Offered
  11.5.3 Bristol-Myers Squibb Schizophrenia Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Bristol-Myers Squibb News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Schizophrenia Therapeutic
Figure Schizophrenia Therapeutic Report Years Considered
Figure Market Research Methodology
Figure Global Schizophrenia Therapeutic Market Size Growth Rate 2013-2023 ($ Millions)
Table Schizophrenia Therapeutic Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Clozapine
Table Major Players of Ziprasidone
Table Major Players of Risperidone
Table Major Players of Lurasidone
Table Major Players of Paliperidone
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
Figure Global Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
Figure Global Clozapine Market Size Growth Rate
Figure Global Ziprasidone Market Size Growth Rate
Figure Global Risperidone Market Size Growth Rate
Figure Global Lurasidone Market Size Growth Rate
Figure Global Paliperidone Market Size Growth Rate
Figure Schizophrenia Therapeutic Consumed in Hospitals
Figure Global Schizophrenia Therapeutic Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Schizophrenia Therapeutic Consumed in Clinics
Figure Global Schizophrenia Therapeutic Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Schizophrenia Therapeutic Consumed in Ambulatory Surgical Centers
Figure Global Schizophrenia Therapeutic Market: Ambulatory Surgical Centers (2013-2018) ($ Millions)
Figure Global Ambulatory Surgical Centers YoY Growth ($ Millions)
Table Global Schizophrenia Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
Figure Global Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
Figure Global Schizophrenia Therapeutic Market Size in Hospitals Growth Rate
Figure Global Schizophrenia Therapeutic Market Size in Clinics Growth Rate
Figure Global Schizophrenia Therapeutic Market Size in Ambulatory Surgical Centers Growth Rate
Table Global Schizophrenia Therapeutic Revenue by Players (2016-2018) ($ Millions)
Table Global Schizophrenia Therapeutic Revenue Market Share by Players (2016-2018)
Figure Global Schizophrenia Therapeutic Revenue Market Share by Players in 2017
Table Global Schizophrenia Therapeutic Key Players Head office and Products Offered
Table Schizophrenia Therapeutic Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Schizophrenia Therapeutic Market Size by Regions 2013-2018 ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Market Share by Regions 2013-2018
Figure Global Schizophrenia Therapeutic Market Size Market Share by Regions 2013-2018
Figure Americas Schizophrenia Therapeutic Market Size 2013-2018 ($ Millions)
Figure APAC Schizophrenia Therapeutic Market Size 2013-2018 ($ Millions)
Figure Europe Schizophrenia Therapeutic Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Schizophrenia Therapeutic Market Size 2013-2018 ($ Millions)
Table Americas Schizophrenia Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table Americas Schizophrenia Therapeutic Market Size Market Share by Countries (2013-2018)
Figure Americas Schizophrenia Therapeutic Market Size Market Share by Countries in 2017
Table Americas Schizophrenia Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table Americas Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
Figure Americas Schizophrenia Therapeutic Market Size Market Share by Type in 2017
Table Americas Schizophrenia Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Americas Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
Figure Americas Schizophrenia Therapeutic Market Size Market Share by Application in 2017
Figure United States Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Canada Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Table APAC Schizophrenia Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table APAC Schizophrenia Therapeutic Market Size Market Share by Countries (2013-2018)
Figure APAC Schizophrenia Therapeutic Market Size Market Share by Countries in 2017
Table APAC Schizophrenia Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table APAC Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
Figure APAC Schizophrenia Therapeutic Market Size Market Share by Type in 2017
Table APAC Schizophrenia Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table APAC Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
Figure APAC Schizophrenia Therapeutic Market Size Market Share by Application in 2017
Figure China Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Japan Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Korea Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure India Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Australia Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Table Europe Schizophrenia Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table Europe Schizophrenia Therapeutic Market Size Market Share by Countries (2013-2018)
Figure Europe Schizophrenia Therapeutic Market Size Market Share by Countries in 2017
Table Europe Schizophrenia Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table Europe Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
Figure Europe Schizophrenia Therapeutic Market Size Market Share by Type in 2017
Table Europe Schizophrenia Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Europe Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
Figure Europe Schizophrenia Therapeutic Market Size Market Share by Application in 2017
Figure Germany Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure France Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure UK Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Italy Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Russia Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Spain Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Schizophrenia Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Schizophrenia Therapeutic Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Schizophrenia Therapeutic Market Size Market Share by Countries in 2017
Table Middle East & Africa Schizophrenia Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Schizophrenia Therapeutic Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Schizophrenia Therapeutic Market Size Market Share by Type in 2017
Table Middle East & Africa Schizophrenia Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Schizophrenia Therapeutic Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Schizophrenia Therapeutic Market Size Market Share by Application in 2017
Figure Egypt Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Israel Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Schizophrenia Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Global Schizophrenia Therapeutic arket Size Forecast (2018-2023) ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Market Share Forecast by Regions
Figure Americas Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure APAC Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Europe Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure United States Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Canada Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Mexico Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Brazil Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure China Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Japan Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Korea Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure India Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Australia Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Germany Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure France Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure UK Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Italy Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Russia Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Spain Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Egypt Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure South Africa Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Israel Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure Turkey Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure GCC Countries Schizophrenia Therapeutic Market Size 2018-2023 ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Market Share Forecast by Type (2018-2023)
Table Global Schizophrenia Therapeutic Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Schizophrenia Therapeutic Market Size Market Share Forecast by Application (2018-2023)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Schizophrenia Therapeutic Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Schizophrenia Therapeutic Market Share (2016-2018)
Table Johnson and Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson and Johnson Schizophrenia Therapeutic Revenue and Gross Margin (2016-2018)
Figure Johnson and Johnson Schizophrenia Therapeutic Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Schizophrenia Therapeutic Revenue and Gross Margin (2016-2018)
Figure Pfizer Schizophrenia Therapeutic Market Share (2016-2018)
Table Astrazeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astrazeneca Schizophrenia Therapeutic Revenue and Gross Margin (2016-2018)
Figure Astrazeneca Schizophrenia Therapeutic Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Schizophrenia Therapeutic Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Schizophrenia Therapeutic Market Share (2016-2018)